Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis.

Lakhrif Z, Moreau A, Hérault B, Di-Tommaso A, Juste M, Moiré N, Dimier-Poisson I, Mévélec MN, Aubrey N.

Front Immunol. 2018 Feb 20;9:317. doi: 10.3389/fimmu.2018.00317. eCollection 2018.

2.

A method to confer Protein L binding ability to any antibody fragment.

Lakhrif Z, Pugnière M, Henriquet C, di Tommaso A, Dimier-Poisson I, Billiald P, Juste MO, Aubrey N.

MAbs. 2016;8(2):379-88. doi: 10.1080/19420862.2015.1116657. Epub 2015 Dec 18.

3.

Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential.

Alvarenga LM, Zahid M, di Tommaso A, Juste MO, Aubrey N, Billiald P, Muzard J.

Toxins (Basel). 2014 Aug 21;6(8):2541-67. doi: 10.3390/toxins6082541. Review.

4.

ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics.

Molina A, Velot L, Ghouinem L, Abdelkarim M, Bouchet BP, Luissint AC, Bouhlel I, Morel M, Sapharikas E, Di Tommaso A, Honoré S, Braguer D, Gruel N, Vincent-Salomon A, Delattre O, Sigal-Zafrani B, André F, Terris B, Akhmanova A, Di Benedetto M, Nahmias C, Rodrigues-Ferreira S.

Cancer Res. 2013 May 1;73(9):2905-15. doi: 10.1158/0008-5472.CAN-12-3565. Epub 2013 Feb 8.

5.

Angiotensin II facilitates breast cancer cell migration and metastasis.

Rodrigues-Ferreira S, Abdelkarim M, Dillenburg-Pilla P, Luissint AC, di-Tommaso A, Deshayes F, Pontes CL, Molina A, Cagnard N, Letourneur F, Morel M, Reis RI, Casarini DE, Terris B, Couraud PO, Costa-Neto CM, Di Benedetto M, Nahmias C.

PLoS One. 2012;7(4):e35667. doi: 10.1371/journal.pone.0035667. Epub 2012 Apr 20.

6.

Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.

di Tommaso A, Juste MO, Martin-Eauclaire MF, Dimier-Poisson I, Billiald P, Aubrey N.

J Biol Chem. 2012 Apr 20;287(17):14149-56. doi: 10.1074/jbc.M112.348912. Epub 2012 Feb 28.

7.

[ATIP, a novel superfamily of microtubule-associated proteins].

Molina A, Rodrigues-Ferreira S, Di Tommaso A, Nahmias C.

Med Sci (Paris). 2011 Mar;27(3):244-6. doi: 10.1051/medsci/2011273244. Epub 2011 Mar 30. French. No abstract available.

8.

8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis.

Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, Cazaubon S, Gruel N, Colasson H, Nicolas A, Chaverot N, Molinié V, Reyal F, Sigal-Zafrani B, Terris B, Delattre O, Radvanyi F, Perez F, Vincent-Salomon A, Nahmias C.

PLoS One. 2009 Oct 1;4(10):e7239. doi: 10.1371/journal.pone.0007239.

9.

Residues in the alternative reading frame tumor suppressor that influence its stability and p53-independent activities.

di Tommaso A, Hagen J, Tompkins V, Muniz V, Dudakovic A, Kitzis A, Ladeveze V, Quelle DE.

Exp Cell Res. 2009 Apr 15;315(7):1326-35. doi: 10.1016/j.yexcr.2009.01.010. Epub 2009 Jan 27.

10.

A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability.

Tompkins VS, Hagen J, Frazier AA, Lushnikova T, Fitzgerald MP, di Tommaso A, Ladeveze V, Domann FE, Eischen CM, Quelle DE.

J Biol Chem. 2007 Jan 12;282(2):1322-33. Epub 2006 Nov 16.

11.

The ink4a/arf locus evolution in primates: characterization of three ARF sequences.

Di Tommaso A, Soler C, Roos C, Kitzis A, Ladeveze V.

DNA Cell Biol. 2004 Mar;23(3):167-73.

PMID:
15068586

Supplemental Content

Loading ...
Support Center